Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Gross Margin: 2009-2020

Historic Gross Margin for Avadel Pharmaceuticals (AVDL) over the last 10 years, with Jun 2020 value amounting to 67.45%.

  • Avadel Pharmaceuticals' Gross Margin fell 1192.00% to 67.45% in Q2 2020 from the same period last year, while for Jun 2020 it was 76.91%, marking a year-over-year decrease of 395.00%. This contributed to the annual value of 74.29% for FY2020, which is 523.00% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Gross Margin of 67.45% as of Q2 2020, which was down 15.62% from 79.93% recorded in Q1 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Gross Margin ranged from a high of 93.99% in Q4 2016 and a low of 67.45% during Q2 2020.
  • Over the past 3 years, Avadel Pharmaceuticals' median Gross Margin value was 80.03% (recorded in 2019), while the average stood at 79.70%.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Gross Margin spiked by 180,421bps in 2016 and then tumbled by 1,237bps in 2018.
  • Avadel Pharmaceuticals' Gross Margin (Quarterly) stood at 93.99% in 2016, then crashed by 563bps to 88.35% in 2017, then tumbled by 887bps to 79.48% in 2018, then plummeted by 144bps to 78.04% in 2019, then plummeted by 1,192bps to 67.45% in 2020.
  • Its Gross Margin was 67.45% in Q2 2020, compared to 79.93% in Q1 2020 and 78.04% in Q4 2019.